How it works.
From a flagged claim to a reviewed report.
Six steps, with a new test only ordered when no usable genetic record already exists.
The claim qualifies for screening
The injury and procedure codes already on the claim, pulled from your existing claims systems, determine whether it warrants pharmacogenomic screening.
The patient only consents once
Through the treating doctor’s portal, the patient consents and authorizes any other check that may need to reference their genetic record.
Check for an existing result
Using that authorization, the patient’s own genetic record is checked without exposing their raw identity. If nothing is found, the nurse case manager orders a test using that same authorization.
The reconciliation engine checks the drug
Gene values and the current drug list are checked for adverse-reaction risk and interactions. No patient identifier is ever passed into this step.
An internal clinician reviews the finding
A Precivo clinician independently reviews the result for accuracy, classifies the risk from Tier A to Tier D, and lists alternative drugs and dosages. They see gene values, never who the patient is.
The treating doctor gets the full report
Once the lab result enters Precivo’s system, gene values and identity are never revealed together until delivered to the treating doctor. They review the report and adjust treatment as needed.
The patient owns the record. Precivo never does.
Precivo owns the workflow, not the genetic record. Since storage lives with the patient, not any one payer, the record stays accessible even if they switch health plans.
Inside Precivo’s system, gene values and identity are never held by the same party at once, except the treating doctor.
Designed to accept results from any lab.
Once a lab is configured, any usable result from it becomes part of the record.
Not locked to one lab
Any CLIA-certified lab’s pharmacogenomic result can be incorporated into the record once that lab is configured.
One requirement: phenotype coverage
The test just needs to cover clinically actionable phenotypes.
No redundant retesting
A patient tested years ago by one lab doesn’t need retesting. A new lab’s result, if requested, just adds any additional phenotypes to the record.
Precivo is in development. This page describes the intended workflow. The current build is a prototype using synthetic data.